Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Indivior (INDV)

Nasdaq Health Care Pharmaceuticals S&P SmallCap 600
$36.28
+0.91 (+2.57%)
Close of Nov 02, 2026 · end-of-day data
Source: Indivior's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2022FY2023FY2024FY2025
Revenue$901.00M$1.09B$1.19B$1.24B
Cost of revenue$151.00M$174.00M$231.00M$246.00M
Gross profit$749.00M$919.00M$957.00M$994.00M
Research & development$74.00M$116.00M$107.00M$97.00M
Selling, general & admin$466.00M$565.00M$612.00M$634.00M
Operating income-$77.00M-$152.00M$38.00M$262.00M
Interest expense$27.00M$35.00M$41.00M$45.00M
Pre-tax income-$86.00M-$145.00M$20.00M$239.00M
Income tax-$43.00M-$19.00M$13.00M$29.00M
Net income-$42.00M-$126.00M$7.00M$210.00M
EBITDA-$61.00M-$137.00M$54.00M$272.00M
EPS (basic)$-0.30$-0.92$0.05$1.68
EPS (diluted)$-0.30$-0.92$0.05$1.64
Diluted shares139.00M137.00M133.00M128.00M
Gross margin83.1%84.1%80.6%80.2%
Operating margin-8.5%-13.9%3.2%21.1%
Net margin-4.7%-11.5%0.6%16.9%

Balance sheet

fiscal years · USD
Fiscal yearFY2022FY2023FY2024FY2025
Cash & equivalents$774.00M$316.00M$319.00M$195.00M
Short-term investments—$94.00M$1.00M$0
Receivables—$254.00M$254.00M$253.00M
Inventory—$126.00M$167.00M$153.00M
Total current assets—$1.26B$827.00M$652.00M
Goodwill—$5.00M$2.00M$2.00M
Total assets—$1.76B$1.32B$1.20B
Total current liabilities—$1.28B$924.00M$914.00M
Short-term debt—$3.00M$18.00M$29.00M
Long-term debt—$237.00M$315.00M$290.00M
Total debt—$240.00M$333.00M$319.00M
Total liabilities—$1.94B$1.65B$1.30B
Shareholders' equity-$15.00M-$184.00M-$337.00M-$98.00M

Cash flow

fiscal years · USD
Fiscal yearFY2022FY2023FY2024FY2025
Operating cash flow-$4.00M-$300.00M$36.00M-$27.00M
Capital expenditures$5.00M$8.00M$29.00M$66.00M
Free cash flow-$9.00M-$308.00M$7.00M-$93.00M
Investing cash flow-$222.00M-$95.00M$69.00M-$66.00M
Financing cash flow-$101.00M-$64.00M-$102.00M-$30.00M
Share buybacks$90.00M$33.00M$173.00M$11.00M
Stock-based compensation$16.00M$21.00M$24.00M$26.00M
Depreciation & amortization$16.00M$15.00M$16.00M$10.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.